Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
309.89
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
37
38
Next >
Finding 20 Dividend Growth Stocks In A Bad Market
December 14, 2022
Starting in 2012, it became more and more difficult for prudent dividend growth stock investors looking for income. The stock market was trading at excessive valuations, and interest rates were at...
Via
Talk Markets
The Bullish Call Eli Lilly Made For Its Next-Gen Obesity Drug, A Rival To Novo, Amgen
December 13, 2022
All eyes are on tirzepatide, but its next-generation weight-loss shot could be even better.
Via
Investor's Business Daily
Pinterest To Rally Around 23%? Here Are 10 Other Price Target Changes For Tuesday
December 13, 2022
Via
Benzinga
Cramers Says These 3 Big Deals Aided Monday's Market Rally: 'When Companies Start Buying Each Other At A Big Premium...'
December 13, 2022
Prominent market commentator Jim Cramer said three corporate deals announced on Monday aided the rally seen at the beginning of the week,
Via
Benzinga
Nasdaq, S&P 500 Futures Soar Amid Optimistic Expectations Concerning Nov. Inflation: Oracle, Tesla, Pinterest Among Early Movers
December 13, 2022
The index futures point to a modestly higher opening for the market on Tuesday, although the November consumer price inflation due ahead of the open could sway sentiment either way depending on how the...
Via
Benzinga
Tesla, Apple, Rivian, Horizon, Paypal: Why These 5 Stocks Are Drawing Investors' Attention Today
December 12, 2022
Major Wall Street indices closed over 1% higher on Monday after last week’s subdued performance.
Via
Benzinga
Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues
December 12, 2022
FDA action on its KRAS-blocking drug could help recently downtrodden Mirati.
Via
Investor's Business Daily
Here's Where Amgen's Loan To Acquire Horizon Therapeutics For $28B Ranks Among M&A Deals In 2022
December 12, 2022
Amgen Inc's (NASDAQ: AMGN) deal to acquire Horizon Therapeutics (NASDAQ: HZNP) requires a sizable loan that ranks among the biggest debt commitments for
Via
Benzinga
Why Horizon Therapeutics Stock Is Soaring Today
December 12, 2022
Amgen's planned acquisition of Horizon could close in the first half of next year.
Via
The Motley Fool
What's Going On With Amgen Stock Today?
December 12, 2022
Amgen Inc (NASDAQ: AMGN) shares are trading lower Monday after the company announced it will acquire Horizon Therapeutics (NASDAQ: HZNP)
Via
Benzinga
Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal
December 12, 2022
HZNP stock is up on news that Horizon Therapeutics is being bought by Amgen in a friendly deal that's positive for both companies.
Via
InvestorPlace
Amgen To Buy Rare Diseases Drugmaker Horizon Therapeutics In $28.3 Billion Deal
December 12, 2022
The deal comes a day after Sanofi dropped out of the bidding process.
Via
Investor's Business Daily
These 2 Nasdaq Stocks Are Soaring on Merger News
December 12, 2022
Find out which companies are attracting interest from prospective buyers.
Via
The Motley Fool
Broadcom-Vmware Deal Draws European Regulatory Attention, Rivian Pauses Mercedes-Partnered EV Van Plans For Europe, Credit Suisse Issued Loan On Suspicious Bills: Top Stories Monday, Dec. 12
December 12, 2022
Reuters Broadcom's Vmware Draws More Regulatory Attention, This Time From EU
Via
Benzinga
Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share
December 12, 2022
Via
Benzinga
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
December 11, 2022
Amgen recently shared positive clinical trial results for a heart disease drug candidate.
Via
The Motley Fool
How An Eli Lilly Decision Could Light Up The Red-Hot Obesity Landscape — Again
December 09, 2022
Eli Lilly is expected to make a key decision for a next-generation obesity drug.
Via
Investor's Business Daily
Why Mirati Therapeutics Stock Lost Half Its Value In Just Three Days
December 08, 2022
The company is still planning a Phase 3 study in non-small cell lung cancer.
Via
Investor's Business Daily
Here's What We Know So Far About Amgen's Obesity Drug As It Trails Novo Nordisk, Eli Lilly
December 08, 2022
Amgen is trying to play catch-up with Novo Nordisk and Eli Lilly.
Via
Investor's Business Daily
This Monster Dividend Stock Isn't Done Growing
December 08, 2022
Is another deal on the way for Johnson & Johnson?
Via
The Motley Fool
Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration
December 08, 2022
Via
Benzinga
Mirati Therapeutics Crashes As The Cancer Rivalry With Amgen Heats Up
December 06, 2022
The combination with Keytruda appears safe, but effectiveness questions persist.
Via
Investor's Business Daily
Mirati Experimental Lung Cancer Drug Shows Favorable Tolerability, Promising Efficacy
December 06, 2022
Via
Benzinga
Is AbbVie Stock a Buy Now?
December 06, 2022
The pharmaceutical company prepared well as Humira approaches its patent cliff next year.
Via
The Motley Fool
Amgen Unusual Options Activity For December 05
December 05, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Amgen. Looking at options history for Amgen (NASDAQ:AMGN) we detected 13 strange trades.
Via
Benzinga
Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi
December 05, 2022
There are now two companies in the ring for a Horizon takeover.
Via
Investor's Business Daily
7 Christmas Stocks to Buy for Happy Holidays
December 05, 2022
This year took a toll on a lot of portfolios, leaving many investors feeling more like a Grinch than looking for Christmas stocks to buy.
Via
InvestorPlace
FTX Collapse: Lessons for Investors
December 03, 2022
Plus a look at "the dumbest index."
Via
The Motley Fool
Stock Market Rally Fights At Key Level On Powell, Inflation Data, Jobs Report: Weekly Review
December 02, 2022
The S&P 500 is fighting for its 200-day, a critical level for the uptrend.
Via
Investor's Business Daily
If Sanofi Opted For Takeover Of Horizon Therapeutics, It Would Be In Cash
December 02, 2022
Via
Benzinga
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.